Study Details

8450-508 2 & 3

Back To Current Studies

Healthy Adults, Age 18-60

Study Number

8450-508 2 & 3

Group

Group 2 & 3

Gender

both

Age

18-60

Location

Daytona Beach, Florida

Compensation

$5,252

Study Dates

Sep. 22 - Dec. 16, 2020

Additional Information

The investigational drug in this research study is being developed for the potential treatment and prevention of Coronavirus Disease 2019 by providing an antibody to the virus that causes COVID-19.  This is the first time the study drug will be given to humans as an injection under the skin surface, but the study drug has previously been administered as an intravenous dose.

 

• Healthy Adults, Age 18-60

• Women must be surgically sterile or postmenopausal


• BMI (body mass index) 18.5-35


• Available for 1 stay of 7 overnights & 4 follow up visits


• Compensation up to $5,252 may be provided for time and participation.

 

Details

Group 2-

Screening: Sep 16, 17 & 18

Check-in: Sep 22
Check-out: Sep 29

Follow Up Visit: Oct 7

Follow Up Visit: Oct 21

Follow Up Visit: Nov 21

Follow Up Visit: Dec 16

 

OR

 

Group 3-

Screening: Sep 16, 17, 18; 21, 22 & 23

Check-In: Sep 28
Check-Out: Oct 5

Follow Up Visit: Oct 13

Follow Up Visit: Oct 27

Follow Up Visit: Nov 27

Follow Up Visit: Dec 22

Study Number

8450-508 2 & 3

Group

Group 2 & 3

Gender

both

Age

18-60

Location

Daytona Beach, Florida

Compensation

$5,252

Study Dates

Sep. 22 - Dec. 16, 2020

Additional Information

The investigational drug in this research study is being developed for the potential treatment and prevention of Coronavirus Disease 2019 by providing an antibody to the virus that causes COVID-19.  This is the first time the study drug will be given to humans as an injection under the skin surface, but the study drug has previously been administered as an intravenous dose.

 

• Healthy Adults, Age 18-60

• Women must be surgically sterile or postmenopausal


• BMI (body mass index) 18.5-35


• Available for 1 stay of 7 overnights & 4 follow up visits


• Compensation up to $5,252 may be provided for time and participation.

 

Details

Group 2-

Screening: Sep 16, 17 & 18

Check-in: Sep 22
Check-out: Sep 29

Follow Up Visit: Oct 7

Follow Up Visit: Oct 21

Follow Up Visit: Nov 21

Follow Up Visit: Dec 16

 

OR

 

Group 3-

Screening: Sep 16, 17, 18; 21, 22 & 23

Check-In: Sep 28
Check-Out: Oct 5

Follow Up Visit: Oct 13

Follow Up Visit: Oct 27

Follow Up Visit: Nov 27

Follow Up Visit: Dec 22

Calculate Your BMI!

Calculate Your BMI!